Kevin J Kenny Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin J Kenny.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin J Kenny. Kevin J Kenny is President of Global Spine in Orthofix Medical Inc. ($OFIX) and Chief Operating Officer in Cardiovascular Systems Inc ($RDYN) and Exec. VP, Sales & Mtkg in Cardiovascular Systems Inc ($RDYN).
Latest Insider Trading Transactions of Kevin J Kenny
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 07 2020 | OFIX | Orthofix Medical I ... | Kenny Kevin J. | President of Global ... | Payment of Exercise | F | 37.09 | 984 | 36,497 | 18,792 | 19.8 K to 18.8 K (-4.98 %) |
Dec 07 2020 | OFIX | Orthofix Medical I ... | Kenny Kevin J. | President of Global ... | Payment of Exercise | F | 37.09 | 984 | 36,497 | 18,792 | 19.8 K to 18.8 K (-4.98 %) |
Jun 10 2020 | OFIX | Orthofix Medical I ... | Kenny Kevin J. | President of Global ... | Option Exercise | A | 0.00 | 10,485 | 0 | 10,485 | |
Dec 05 2019 | OFIX | Orthofix Medical I ... | Kenny Kevin J. | President of Global ... | Option Exercise | A | 44.96 | 33,395 | 1,501,439 | 33,395 | |
Dec 05 2019 | OFIX | Orthofix Medical I ... | Kenny Kevin J. | President of Global ... | Grant | A | 0.00 | 10,009 | 0 | 10,009 | 0 to 10 K |
Aug 17 2017 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 30.71 | 2,059 | 63,240 | 151,280 | 153.3 K to 151.3 K (-1.34 %) |
Aug 17 2017 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 30.76 | 2,674 | 82,256 | 153,339 | 156 K to 153.3 K (-1.71 %) |
Aug 09 2017 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 37,428 | 0 | 156,013 | 118.6 K to 156 K (+31.56 %) |
Aug 09 2017 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 12,476 | 0 | 118,585 | 106.1 K to 118.6 K (+11.76 %) |
Feb 22 2017 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 27.88 | 539 | 15,028 | 105,004 | 105.5 K to 105 K (-0.51 %) |
Nov 17 2016 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 26.01 | 24,441 | 635,737 | 105,543 | 130 K to 105.5 K (-18.80 %) |
Aug 30 2016 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | D | 0.00 | 38,247 | 0 | 129,984 | 168.2 K to 130 K (-22.73 %) |
Aug 24 2016 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 23.95 | 3,166 | 75,832 | 168,231 | 171.4 K to 168.2 K (-1.85 %) |
Aug 10 2016 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 16,373 | 0 | 171,397 | 155 K to 171.4 K (+10.56 %) |
Aug 10 2016 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 49,119 | 0 | 155,024 | 105.9 K to 155 K (+46.38 %) |
Sep 03 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 23.85 | 5,289 | 126,153 | 105,330 | 110.6 K to 105.3 K (-4.78 %) |
Aug 31 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | D | 0.00 | 6,839 | 0 | 110,619 | 117.5 K to 110.6 K (-5.82 %) |
Aug 19 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 23.98 | 2,183 | 52,357 | 117,458 | 119.6 K to 117.5 K (-1.82 %) |
Aug 19 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Sell | S | 24.01 | 1,730 | 41,538 | 119,641 | 121.4 K to 119.6 K (-1.43 %) |
Aug 12 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 12,749 | 0 | 121,371 | 108.6 K to 121.4 K (+11.74 %) |
Aug 12 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 19,124 | 0 | 108,622 | 89.5 K to 108.6 K (+21.37 %) |
Aug 12 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J. | Chief Operating Off ... | Grant | A | 0.00 | 19,123 | 0 | 89,498 | 70.4 K to 89.5 K (+27.17 %) |
Mar 03 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Chief Operating Off ... | Grant | A | 0.00 | 3,766 | 0 | 70,375 | 66.6 K to 70.4 K (+5.65 %) |
Feb 27 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Chief Operating Off ... | Sell | S | 37.00 | 2,294 | 84,878 | 66,609 | 68.9 K to 66.6 K (-3.33 %) |
Feb 25 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 35.51 | 3,833 | 136,120 | 68,903 | 72.7 K to 68.9 K (-5.27 %) |
Feb 02 2015 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 35.00 | 4,212 | 147,420 | 72,736 | 76.9 K to 72.7 K (-5.47 %) |
Nov 20 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 28.69 | 4,500 | 129,095 | 76,948 | 81.4 K to 76.9 K (-5.52 %) |
Sep 05 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 28.85 | 3,528 | 101,789 | 81,448 | 85 K to 81.4 K (-4.15 %) |
Aug 25 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.45 | 1,201 | 35,367 | 84,976 | 86.2 K to 85 K (-1.39 %) |
Aug 25 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.36 | 659 | 19,347 | 86,177 | 86.8 K to 86.2 K (-0.76 %) |
Aug 25 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 28.52 | 1,054 | 30,059 | 86,836 | 87.9 K to 86.8 K (-1.20 %) |
Aug 20 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.28 | 2,117 | 61,984 | 87,890 | 90 K to 87.9 K (-2.35 %) |
Aug 20 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 6,386 | 0 | 89,378 | 83 K to 89.4 K (+7.69 %) |
Aug 20 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 9,579 | 0 | 82,992 | 73.4 K to 83 K (+13.05 %) |
Aug 20 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 9,579 | 0 | 73,413 | 63.8 K to 73.4 K (+15.01 %) |
Jul 18 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 28.83 | 3,007 | 86,700 | 63,834 | 66.8 K to 63.8 K (-4.50 %) |
Apr 28 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.00 | 9,480 | 274,920 | 66,841 | 76.3 K to 66.8 K (-12.42 %) |
Apr 28 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 28.47 | 6,004 | 170,914 | 76,321 | 82.3 K to 76.3 K (-7.29 %) |
Feb 21 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 36.72 | 2,742 | 100,681 | 82,325 | 85.1 K to 82.3 K (-3.22 %) |
Feb 21 2014 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 35.55 | 4,037 | 143,531 | 85,067 | 89.1 K to 85.1 K (-4.53 %) |
Nov 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.90 | 4,296 | 128,458 | 89,104 | 93.4 K to 89.1 K (-4.60 %) |
Nov 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 29.83 | 5,018 | 149,673 | 93,400 | 98.4 K to 93.4 K (-5.10 %) |
Oct 24 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 27.31 | 5,608 | 153,154 | 98,418 | 104 K to 98.4 K (-5.39 %) |
Oct 18 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 22.95 | 4,182 | 95,977 | 104,026 | 108.2 K to 104 K (-3.86 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 19.90 | 142 | 2,826 | 108,208 | 108.4 K to 108.2 K (-0.13 %) |
Sep 23 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.32 | 1,179 | 23,957 | 108,350 | 109.5 K to 108.4 K (-1.08 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.91 | 1,171 | 24,486 | 109,529 | 110.7 K to 109.5 K (-1.06 %) |
Sep 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.98 | 695 | 14,581 | 110,700 | 111.4 K to 110.7 K (-0.62 %) |
Sep 13 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 1,478 | 0 | 111,395 | 109.9 K to 111.4 K (+1.34 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 2,554 | 0 | 109,917 | 107.4 K to 109.9 K (+2.38 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 2,554 | 0 | 107,363 | 104.8 K to 107.4 K (+2.44 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 8,515 | 0 | 104,809 | 96.3 K to 104.8 K (+8.84 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 4,257 | 0 | 96,294 | 92 K to 96.3 K (+4.63 %) |
Sep 06 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 4,257 | 0 | 92,037 | 87.8 K to 92 K (+4.85 %) |
Aug 30 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.57 | 260 | 5,348 | 87,780 | 88 K to 87.8 K (-0.30 %) |
Aug 30 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.72 | 1,128 | 23,372 | 88,040 | 89.2 K to 88 K (-1.27 %) |
Aug 30 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.50 | 511 | 10,476 | 89,168 | 89.7 K to 89.2 K (-0.57 %) |
Aug 27 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.88 | 776 | 16,203 | 89,679 | 90.5 K to 89.7 K (-0.86 %) |
Aug 27 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 21.29 | 1,115 | 23,738 | 90,455 | 91.6 K to 90.5 K (-1.22 %) |
Aug 27 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.88 | 505 | 10,544 | 91,570 | 92.1 K to 91.6 K (-0.55 %) |
Aug 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.48 | 5 | 102 | 92,075 | 92.1 K to 92.1 K (-0.01 %) |
Aug 19 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 20.54 | 643 | 13,207 | 92,080 | 92.7 K to 92.1 K (-0.69 %) |
Aug 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 21.44 | 74 | 1,587 | 92,723 | 92.8 K to 92.7 K (-0.08 %) |
Aug 15 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 21.19 | 2,455 | 52,022 | 92,797 | 95.3 K to 92.8 K (-2.58 %) |
Jul 26 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 1,478 | 0 | 95,252 | 93.8 K to 95.3 K (+1.58 %) |
May 30 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 19.95 | 4,182 | 83,431 | 93,112 | 97.3 K to 93.1 K (-4.30 %) |
Apr 26 2013 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 17.54 | 7,187 | 126,088 | 97,294 | 104.5 K to 97.3 K (-6.88 %) |
Nov 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 10.68 | 278 | 2,969 | 102,519 | 102.8 K to 102.5 K (-0.27 %) |
Nov 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 11.22 | 3,038 | 34,086 | 102,797 | 105.8 K to 102.8 K (-2.87 %) |
Aug 28 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.03 | 75 | 677 | 105,835 | 105.9 K to 105.8 K (-0.07 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.90 | 286 | 2,545 | 105,910 | 106.2 K to 105.9 K (-0.27 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.02 | 77 | 695 | 106,196 | 106.3 K to 106.2 K (-0.07 %) |
Aug 23 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 9.19 | 454 | 4,173 | 106,273 | 106.7 K to 106.3 K (-0.43 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.97 | 334 | 2,996 | 106,727 | 107.1 K to 106.7 K (-0.31 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.75 | 346 | 3,028 | 107,061 | 107.4 K to 107.1 K (-0.32 %) |
Aug 20 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.73 | 297 | 2,593 | 107,407 | 107.7 K to 107.4 K (-0.28 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Sell | S | 8.92 | 259 | 2,310 | 107,704 | 108 K to 107.7 K (-0.24 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 11,820 | 0 | 107,963 | 96.1 K to 108 K (+12.29 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 5,911 | 0 | 96,143 | 90.2 K to 96.1 K (+6.55 %) |
Aug 15 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 5,911 | 0 | 90,232 | 84.3 K to 90.2 K (+7.01 %) |
May 31 2012 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Payment of Exercise | F | 9.34 | 7,771 | 72,612 | 84,321 | 92.1 K to 84.3 K (-8.44 %) |
Oct 26 2011 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 25,000 | 0 | 89,833 | 64.8 K to 89.8 K (+38.56 %) |
Aug 10 2011 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 14,833 | 0 | 64,833 | 50 K to 64.8 K (+29.67 %) |
May 10 2011 | RDYN | Cardiovascular Sys ... | Kenny Kevin J | Exec. VP, Sales & M ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1